Similar rates of BRAF mutations are present in primary and metastatic melanomas, as well as in melanoma cell lines, suggesting that BRAF mutations occur before tumor progression and dissemination and their incidence remains constant during tumor progression. This evidence concerns the gene BRAF and metastatic melanoma.